Royalty Pharma Announces Withdrawal of Judicial Review and Lapse of Offer

New York, NY – June 18, 2013 - Royalty Pharma announced today that it had withdrawn its request for a judicial review of the Irish Takeover Panel’s decision requiring it to lapse its offer for Elan Corporation, plc (NYSE: ELN) if, among other things, Elan shareholders approved the Share Repurchase Program.

© 2014 Royalty Pharma, RP Management LLC. All Rights Reserved.